7Baggers
Quarterly
Annual
    Unit: USD2025-07-31 2025-04-30 2025-01-31 2024-10-31 2024-07-31 2024-04-30 2024-01-31 2023-10-31 2023-07-31 2023-04-30 2023-01-31 2022-10-31 2022-07-31 2022-04-30 2022-01-31 
      
                   
      cash flows from operating activities:
                   
      net income
    -27,763,000 -35,641,000 -17,064,000 -28,127,000 -23,149,000 -35,707,000 -28,578,000 -30,976,000 -32,049,000 -38,826,000 -33,808,000 -33,892,000 -33,413,000 -39,633,000 -43,343,000 
      adjustments to reconcile net income to net cash from operating activities:
                   
      stock-based compensation
    37,555,000 30,643,000 27,956,000 28,428,000 30,136,000 28,620,000 24,271,000 23,959,000 24,823,000 24,179,000 18,849,000 19,141,000 17,282,000 16,971,000 29,144,000 
      amortization of deferred contract costs
    10,030,000 9,421,000 9,010,000 9,025,000 8,666,000 8,313,000 8,104,000 7,743,000 7,281,000 6,660,000 6,391,000 6,264,000 5,577,000 5,407,000 4,537,000 
      depreciation and amortization
    4,766,000 2,606,000 2,747,000 2,636,000 2,606,000 2,126,000 1,881,000 2,237,000 1,319,000 1,526,000 1,692,000 1,026,000 935,000 965,000 650,000 
      benefit from credit losses
    368,000 232,000 174,000 1,788,000 -299,000 668,000 303,000 423,000 700,000 594,000 479,000 483,000 -12,000 -143,000  
      value of common stock donated to charity
    751,000 1,109,000 1,012,000 1,417,000   1,371,000 1,427,000   4,260,000  
      amortization of (discount) premium on marketable securities
    -255,000 -399,000 -474,000 -562,000 -556,000 -487,000          
      non-cash foreign exchange (gain) loss
    -18,000 227,000    -295,000          
      fair value adjustments to contingent consideration
      -86,000 -137,000          
      other
    19,000 9,000 -153,000 -286,000 7,000 280,000 -485,000 -358,000 474,000 20,000 795,000 -264,000    
      changes in operating assets and liabilities:
                   
      accounts receivable
    2,441,000 9,108,000 -5,136,000 -20,916,000 10,813,000 9,876,000 -21,277,000 -1,657,000 -2,120,000 11,046,000 -20,527,000 -10,745,000 -5,362,000 21,984,000 -28,664,000 
      prepaid expenses and other current assets
    1,889,000 3,147,000 -5,264,000 639,000 -1,020,000 -984,000 -5,359,000 3,975,000 -2,774,000 745,000 -1,494,000 1,980,000 -505,000 3,615,000 -13,179,000 
      deferred contract costs
    -12,944,000 -11,870,000 -13,407,000 -12,755,000 -11,279,000 -10,730,000 -12,510,000 -11,591,000 -11,539,000 -9,479,000 -9,246,000 -6,562,000 -6,456,000 -8,205,000 -11,050,000 
      rou assets and liabilities
    96,000 -410,000 -184,000 -184,000 785,000 1,522,000 2,372,000 912,000 286,000 705,000 865,000 -127,000 1,738,000 879,000  
      other assets
    -8,048,000 -403,000 477,000 -1,176,000 393,000 277,000 553,000 635,000 -579,000 -380,000 678,000 512,000 -93,000 614,000 -730,000 
      accounts payable
    -181,000 -978,000 -586,000 -1,682,000 156,000 -1,800,000 560,000 4,174,000 -1,720,000 405,000 880,000 -556,000 554,000 28,000 865,000 
      accrued expenses and other current liabilities
    8,421,000 -7,203,000 1,589,000 -1,247,000 10,703,000 -7,351,000 11,669,000 -5,976,000 5,933,000 9,364,000 8,474,000 -7,818,000 6,949,000 -2,530,000 9,959,000 
      deferred revenue
    -10,054,000 24,547,000 16,370,000 11,689,000 -17,457,000 25,285,000 25,745,000 1,892,000 -8,757,000 15,228,000 25,473,000 4,718,000 -3,474,000 13,177,000 27,833,000 
      other long-term liabilities
    -121,000 -1,000 195,000 -130,000 -50,000 -81,000 442,000 627,000 -479,000 -19,000 -15,000 8,000 7,000 10,000 -733,000 
      net cash from operating activities
    6,952,000 24,144,000 17,083,000 -11,410,000 11,612,000 19,395,000 3,821,000 -2,003,000 -17,517,000 22,549,000 12,000 -23,920,000 -16,321,000 17,921,000 -24,530,000 
      capex
    -3,419,000 -1,272,000 -1,878,000 -2,838,000 -4,378,000 -7,954,000 -7,360,000 -3,908,000 -1,175,000 -892,000 -1,934,000 -4,144,000 -8,361,000 -2,266,000 -1,423,000 
      free cash flows
    3,533,000 22,872,000 15,205,000 -14,248,000 7,234,000 11,441,000 -3,539,000 -5,911,000 -18,692,000 21,657,000 -1,922,000 -28,064,000 -24,682,000 15,655,000 -25,953,000 
      cash flows from investing activities:
                   
      cash paid for acquisition, net of cash acquired
                   
      purchases of property and equipment
    -2,609,000 -217,000 -1,087,000 -1,923,000 -3,309,000 -6,915,000 -6,322,000 -3,012,000 -387,000 -40,000 -1,381,000 -4,222,000 -7,884,000 -1,960,000 -1,200,000 
      capitalized internal-use software costs
    -810,000 -1,055,000 -791,000 -915,000 -1,069,000 -1,039,000 -1,038,000 -896,000 -788,000 -852,000 -553,000 78,000 -477,000 -306,000 -223,000 
      purchases of marketable securities
    -22,751,000 -52,364,000 -38,430,000 -37,446,000 -82,449,000 -59,650,000 -56,137,000 -70,530,000 -75,095,000 -46,297,000 -23,343,000 -70,998,000 -122,343,000 -421,537,000 -4,026,000 
      maturities of marketable securities
    39,325,000 63,215,000 36,267,000 32,086,000 70,000,000 57,000,000 63,000,000 58,448,000 64,803,000 71,486,000 43,300,000 62,399,000 134,708,000 16,000,000 3,700,000 
      return of principal on marketable securities
    7,495,000 113,258,000              
      net cash from investing activities
    -160,550,000 122,837,000 -841,000 -8,198,000 -16,827,000 -10,604,000 -497,000 -15,991,000 -27,785,000 24,297,000 18,023,000 -12,743,000 4,004,000 -407,803,000 -1,749,000 
      cash flows from financing activities:
                   
      proceeds from exercise of common stock options
    2,596,000 605,000 3,224,000 1,477,000 1,170,000 1,035,000 1,314,000 -1,384,000 5,122,000 2,211,000 4,119,000 1,802,000 2,781,000 2,630,000 3,721,000 
      proceeds from stock associated with employee stock purchase plan
      2,953,000   2,789,000         
      payments of deferred purchase consideration
      -2,916,000         
      net cash from financing activities
      6,177,000 1,477,000   4,103,000 1,673,000 5,122,000 2,211,000 4,119,000 1,802,000 2,781,000 2,630,000 463,306,000 
      effect of foreign currency exchange rate changes on cash, cash equivalents, and restricted cash
    -209,000 851,000 -669,000 324,000 238,000 -337,000 331,000 -511,000 -115,000 -180,000 1,043,000 -630,000 -193,000 -1,075,000 -66,000 
      net change in cash, cash equivalents, and restricted cash
    -146,329,000 148,437,000 21,750,000 -17,807,000 945,000 6,573,000 7,758,000 -16,832,000 -40,295,000 48,877,000 23,197,000 -35,491,000 -9,729,000 -388,327,000 436,961,000 
      cash, cash equivalents, and restricted cash, beginning of period
    83,592,000 72,131,000 72,623,000 482,973,000 
      cash, cash equivalents, and restricted cash, end of period
    -146,329,000 232,029,000 21,750,000 -17,807,000 945,000 78,704,000 7,758,000 -16,832,000 -40,295,000 121,500,000 23,197,000 -35,491,000 -9,729,000 94,646,000 436,961,000 
      net cash provided by/(used in) financing activities
     605,000              
      adjustments to reconcile net income to net cash provided by/(used in) operating activities:
                   
      fixed asset write off
                   
      non-cash foreign exchange loss
       -317,000   -13,000 -37,000 200,000 310,000   -210,000 505,000  
      fixed asset write offs
                   
      net cash (used in)/provided by financing activities
         -1,881,000          
      proceeds from issuance of common stock upon initial public offering, net of offering costs
                   
      investment from redeemable non-controlling interest
                  
      payment of deferred offering costs
                  -2,673,000 
      repurchase of shares related to early exercised options
                  -2,000 
      supplemental cash flow disclosure:
                   
      cash paid for income taxes, net of refunds
              38,000    108,000 
      non-cash investing and financing activities:
                   
      stock-based compensation capitalized to internal-use software
              325,000    333,000 
      net change in capitalized internal-use software development costs in accrued expenses
                 -7,000 
      unrealized net gain on marketable investment securities
                   
      net change to property and equipment
              70,000    1,000 
      vesting of early exercised options
              -26,000    144,000 
      common stock option receivables
                  -1,155,000 
      conversion of convertible preferred stock to common stock
                   
      deferred offering costs reclassed to stockholders’ equity
                   
      asset retirement obligation
              26,000     
      common stock issuance, acquisition
                   
      contingent consideration, acquisition
                   
      indemnity holdbacks, acquisition
                   
      amortization of discount/premium on marketable securities
           588,000 520,000 471,000 583,000 538,000 202,000 13,000 56,000 
      cash paid for acquisition; net of cash acquired
           -1,000        
      non-cash foreign exchange gain
              -57,000     
      repurchase of common shares
                   
      unrealized net income on marketable investment securities
              2,399,000    -20,000 
      deferred offering costs included in accounts payable and accrued expenses and other current liabilities
                   
      deferred income taxes
                 4,000 -57,000 
      benefit from bad debt
                  186,000 
      proceeds from issuance of common stock upon initial public offering, net of underwriting discounts
                   
      unrealized foreign exchange gain
                   
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.